ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Aurobindo Pharma U.s.a., INC.

Official 2024 U.S. DOL Form 5500 summary for Aurobindo Pharma U.s.a., INC. (Aurobindo Pharma U.s.a., INC. 401(k) Plan · EIN 20-0962874 · PN 001): $48.86M net assets, 457 active participants, and $29.97 per $10,000 (29.97 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAurobindo Pharma U.s.a., INC.
Filing IdentifierAurobindo Pharma U.s.a., INC. 401(k) Plan · EIN 20-0962874 · PN 001
Plan Category & State401(k) Defined Contribution (NJ)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$48.86M
Active Participants457
Direct Admin Fee Rate$29.97 per $10,000 (29.97 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderHUB / Global Retirement Partners
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI